References
1. Bougie O., Yap M., Sikora L., Flaxman T., et al. Influence of race/ethnicity on prevalence and presentation of endometriosis: a systematic review and meta-analysis. BJOG. 2019; 126: 1104-15.
2. Cranney R., Condous G., Reid S. An update on the diagnosis, surgical management, and fertility outcomes for women with endometrioma. Acta Obstet Gynecol Scand. 2017; 96 (6): 633-43. DOI: https://doi.org/10.1111/aogs.13114
3. Llarena N., Flyckt R., Falcone T. Fertility preservation in women with endometriosis reproductive health. Clin Med Insights Reprod Health. 2019; 13: 1-8.
4. Exacoustos C., et al. Recurrence of endometriomas after laparoscopic removal: sonographic and clinical follow-up and indication for second surgery. Minim Invasive Gynecol. 2006; 13 (4): 281-8.
5. Nirgianakis K., Ma L., McKinnon B., et al. Recurrence patterns after surgery in patients with different endometriosis subtypes: a long-term hospital-based cohort study. J Clin Med. 2020; 9 (2): 496. DOI: https://doi.org/10.3390/jcm9020496
6. Guo S.W. Recurrence of endometriosis and its control. Hum Reprod Update. 2009; 15 (4): 441-61. DOI: https://doi.org/10.1093/humupd/dmp007
7. Li X.Y., Chao X.P., Leng J.H., et al. Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women. J Ovarian Res. 2019; 12 (1). DOI: https://doi.org/10.1186/s13048-019-0552-y
8. Hidari T., Hirata T., Arakawa T., et al. Contralateral ovarian endometrioma recurrence after unilateral salpingo-oophorectomy. BMC Womens Health. 2019; 19 (1). DOI: https://doi.org/10.1186/s12905-019-0760-z
9. Coccia M.E., Rizzello F., Palagiano A., et al. Long-term follow-up after laparoscopic treatment for endometriosis: multivariate analysis of predictive factors for recurrence of endometriotic lesions and pain. Eur J Obstet Gynecol Reprod Biol. 2011; 157: 78-83.
10. Vignali M., Bianchi S., Candiani M., et al. Surgical treatment of deep endometriosis and risk of recurrence. J Minim Invasive Gynecol. 2005; 12: 508-13.
11. Campo S., Campo V., Gambadauro P. Is a positive family history of endometriosis a risk factor for endometrioma recurrence after laparoscopic surgery? Reprod Sci. 2014; 21: 526-31.
12. Seo J.W., Lee D.Y., Yoon B.K., et al. The age-related recurrence of endometrioma after conservative surgery. Eur J Obstet Gynecol Reprod Biol. 2017; 208: 81-5.
13. Selcuk S., Cam C., Koc N., Kucukbas M., Ozkaya E., Eser A., et al. Evaluation of risk factors for the recurrence of ovarian endometriomas. Eur J Obstet Gynecol Reprod Biol. 2016; 203: 56-60.
14. Koga K., et al. Recurrence of ovarian endometrioma after laparoscopic excision. Hum Reprod. 2006; 21: 2171-4.
15. Bozdag G. Recurrence of endometriosis: risk factors, mechanisms and biomarkers. Womens Health. 2015; 11 (5): 693-9. DOI: https://doi.org/10.2217/whe.15.56
16. Somigliana E., Vigano P., Benaglia L., et al. Ovarian stimulation and endometriosis progression or recurrence: a systematic review. Reprod Biomed Online. 2018; 38 (2): 185-94.
17. Kiigiikba§ M., Kurek Eken M., Ilhan G., et al. Which factors are associated with the recurrence of endometrioma after cystectomy? J Obstet Gynaecol. 2018; 38: 372-6.
18. Tobiume T., Kotani Y., Takaya H., et al. Determinant factors of postoperative recurrence of endometriosis: difference between endometrioma and pain. Eur J Ob-stet Gynecol Reprod Biol. 2016; 205: 54-9.
19. Somigliana E., Benaglia L., Vercellini P., et al. Recurrent endometrioma and ovarian reserve: biological connection or surgical paradox? Am J Obstet Gynecol. 2011; 204: 525-9.
20. Roman H. Endometriosis surgery and preservation of fertility, what surgeons should know. J Visc Surg. 2018; 155: S31-6.
21. Brown J., Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014; 3: CD009590. DOI: https://doi.org/10.1002/14651858.CD009590.pub2
22. Shaltout M.F., Elsheikhah A., Maged A.M., et al. A randomized controlled trial of a new technique for laparoscopic management of ovarian endometriosis preventing recurrence and keeping ovarian reserve. J Ovarian Res. 2019; 12 (1). DOI: https://doi.org/10.1186/s13048-019-0542-0
23. Hutchinson R.W., George K., Johns D., et al. Hemostatic efficacy and tissue reaction of oxidized regenerated cellulose hemostats. Cellulose. 2013; 20 (1): 53745.
24. Vercellini P., Somigliana E., Daguati R., et al. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol. 2008; 198 (5): 504.e1-5.
25. Lee S.R., Yi K.W., Song J.Y., et al. Efficacy and safety of long-term use of di-enogest in women with ovarian endometrioma. Reprod Sci. 2018; 25 (3): 341-6. DOI: https://doi.org/10.1177/1933719117725820
26. Kim M.K., Chon S.J., Lee J.H., et al. Postoperative levonorgestrel-releasing intrauterine system insertion after gonadotropin-releasing hormone agonist treatment for preventing endometriotic cyst recurrence: a prospective observational study. Re-prod Sci (Thousand Oaks, Calif). 2018; 25 (1): 39-43.
27. Cho S., Jung J.A., Lee Y., et al. Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence. Acta Obstet Gynecol Scand. 2014; 93 (1): 38-44.
28. Jee B.C., Lee J.Y., Suh C.S., Kim S.H., Choi Y.M., Moon S.Y. Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery. Fertil Steril. 2009; 91 (1): 40-5.
29. Rahmioglu N., Nyholt D.R., Morris A.P., et al. Genetic variants underlying risk of endometriosis: insights from meta-analysis of eight genome-wide association and replication datasets. Hum Reprod Update. 2014; 20 (5): 702-16. URL: https://doi.org/10.1093/humupd/dmu015
30. Melkozerova O.A., Bashmakova N.V., Okulova E.O. Genetic and epigenetic mechanisms of infertility associated with genital endometriosis. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2019; (8): 26-32. (in Russian)
31. Zhang L., Xiong W., Xiong Y., et al. 173-Estradiol promotes vascular endothelial growth factor expression via the Wnt/0-catenin pathway during the pathogenesis of endometriosis. Mol Hum Reprod. 2016; 22 (7): 526-35.
32. Bulun S.E., Yilmaz B.D., Sison C., et al. Endometriosis. Endocr Rev. 2019; 40 (4): 1048-79.
33. Bulun S.E. Molecular biology of endometriosis: from aromatase to genomic abnormalities. Semin Reprod Med. 2015; 33 (3): 220-4.
34. Attar E., et al. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab. 2009; 94 (2): 623-31.
35. Han S.J., Jung S.Y., Wu S.P., et al. Estrogen receptor beta modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 2015; 163: 960-74. DOI: https://doi.org/10.1016/_i.cell.2015.10.034
36. Monsivais D., Dyson M.T., Yin P., et al. Estrogen receptor 0 regulates endometriotic cell survival through serum and glucocorticoid-regulated kinase activation. Fertil Steril. 2016; 105: 1266-73. DOI: https://doi.org/10.1016/i.fertnstert.2016.01.012
37. Du Yu, Zhang Zh., Xiong W., et al. Estradiol promotes EMT in endometriosis via MALAT1/miR200s sponge function. Reproduction. 2018 Nov 1. pii: REP-18-0424.R2.
38. Strygina V.A. Recidiviruyushchie endometrioidnye obrazovaniya yaichnikov. Morfofunkcional‘noe sostoyanie: Autoabstact of Diss. Moscow, 2018. (in Russian)
39. Krasil’nikova L.V. Kliniko-morfologicheskie aspekty formirovaniya endometri-oidnyh kist yaichnikov: Autoabstact of Diss. Moscow, 2017. (in Russian)
40. Sills E.S., Alper M.M., Walsh A.P. Ovarian reserve screening in infertility: practical applications and theoretical directions for research. Eur J Obstet Gynecol Reprod Biol. 2009; 146 (1): 30-6.